Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Lees belangrijke informatie Sluit belangrijke informatie false nl nl false false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • IW
    $90,71

    per maart 28, 2024
  • YTD RETURNS
    --

    per maart 28, 2024
  • Totaal belegd vermogen
    $543,21M

    per maart 28, 2024
  • Jaarlijkse lopende kosten (TER)
    0,36%
  • Introductiedatum
    12-20-2011

Fund Description

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Overzicht

Fund Highlights

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Rendementen

Vergoedingen

Posities

Portefeuille

Uitkeringen

Team

Literature

PPH